These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 9728642)

  • 1. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.
    Stein MB; Liebowitz MR; Lydiard RB; Pitts CD; Bushnell W; Gergel I
    JAMA; 1998 Aug; 280(8):708-13. PubMed ID: 9728642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa.
    Stein DJ; Berk M; Els C; Emsley RA; Gittelson L; Wilson D; Oakes R; Hunter B
    S Afr Med J; 1999 Apr; 89(4):402-6. PubMed ID: 10341825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
    Liebowitz MR; Gelenberg AJ; Munjack D
    Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation.
    Stein MB; Chartier MJ; Hazen AL; Kroft CD; Chale RA; Coté D; Walker JR
    J Clin Psychopharmacol; 1996 Jun; 16(3):218-22. PubMed ID: 8784653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study.
    Stein DJ; Versiani M; Hair T; Kumar R
    Arch Gen Psychiatry; 2002 Dec; 59(12):1111-8. PubMed ID: 12470127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.
    Liebowitz MR; Stein MB; Tancer M; Carpenter D; Oakes R; Pitts CD
    J Clin Psychiatry; 2002 Jan; 63(1):66-74. PubMed ID: 11838629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder.
    Stein DJ; Stein MB; Goodwin W; Kumar R; Hunter B
    Psychopharmacology (Berl); 2001 Nov; 158(3):267-72. PubMed ID: 11713616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
    Van Ameringen MA; Lane RM; Walker JR; Bowen RC; Chokka PR; Goldner EM; Johnston DG; Lavallee YJ; Nandy S; Pecknold JC; Hadrava V; Swinson RP
    Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder.
    Wagner KD; Berard R; Stein MB; Wetherhold E; Carpenter DJ; Perera P; Gee M; Davy K; Machin A
    Arch Gen Psychiatry; 2004 Nov; 61(11):1153-62. PubMed ID: 15520363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study.
    Stein MB; Sareen J; Hami S; Chao J
    Am J Psychiatry; 2001 Oct; 158(10):1725-7. PubMed ID: 11579011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group.
    Baldwin D; Bobes J; Stein DJ; Scharwächter I; Faure M
    Br J Psychiatry; 1999 Aug; 175():120-6. PubMed ID: 10627793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
    Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
    Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled-release paroxetine in the treatment of patients with social anxiety disorder.
    Lepola U; Bergtholdt B; St Lambert J; Davy KL; Ruggiero L
    J Clin Psychiatry; 2004 Feb; 65(2):222-9. PubMed ID: 15003077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
    Stein MB; Fyer AJ; Davidson JR; Pollack MH; Wiita B
    Am J Psychiatry; 1999 May; 156(5):756-60. PubMed ID: 10327910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxetine in social anxiety disorder: a randomized placebo-controlled study.
    Allgulander C
    Acta Psychiatr Scand; 1999 Sep; 100(3):193-8. PubMed ID: 10493085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic advances: paroxetine for the treatment of social anxiety disorder.
    Lydiard RB; Bobes J
    Depress Anxiety; 2000; 11(3):99-104. PubMed ID: 10875050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
    Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
    J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.
    Rickels K; Mangano R; Khan A
    J Clin Psychopharmacol; 2004 Oct; 24(5):488-96. PubMed ID: 15349004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH; Pigotti TA; Perera P; Dillingham KE; Carfagno ML; Pitts CD
    J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.